JP2022105649A5 - - Google Patents

Download PDF

Info

Publication number
JP2022105649A5
JP2022105649A5 JP2022084726A JP2022084726A JP2022105649A5 JP 2022105649 A5 JP2022105649 A5 JP 2022105649A5 JP 2022084726 A JP2022084726 A JP 2022084726A JP 2022084726 A JP2022084726 A JP 2022084726A JP 2022105649 A5 JP2022105649 A5 JP 2022105649A5
Authority
JP
Japan
Prior art keywords
weight
parts
tablet composition
composition according
crude drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022084726A
Other languages
English (en)
Japanese (ja)
Other versions
JP7475393B2 (ja
JP2022105649A (ja
Filing date
Publication date
Priority claimed from JP2018104527A external-priority patent/JP7133982B2/ja
Application filed filed Critical
Publication of JP2022105649A publication Critical patent/JP2022105649A/ja
Publication of JP2022105649A5 publication Critical patent/JP2022105649A5/ja
Application granted granted Critical
Publication of JP7475393B2 publication Critical patent/JP7475393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022084726A 2017-08-10 2022-05-24 錠剤組成物 Active JP7475393B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017156131 2017-08-10
JP2017156131 2017-08-10
JP2018104527A JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018104527A Division JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物

Publications (3)

Publication Number Publication Date
JP2022105649A JP2022105649A (ja) 2022-07-14
JP2022105649A5 true JP2022105649A5 (cg-RX-API-DMAC10.html) 2023-04-18
JP7475393B2 JP7475393B2 (ja) 2024-04-26

Family

ID=65636911

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018104528A Active JP7602857B2 (ja) 2017-08-10 2018-05-31 加齢性肥満改善剤及び脂肪分解力改善剤
JP2018104527A Active JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物
JP2022084726A Active JP7475393B2 (ja) 2017-08-10 2022-05-24 錠剤組成物
JP2022084727A Pending JP2022105650A (ja) 2017-08-10 2022-05-24 加齢性肥満改善剤及び脂肪分解力改善剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018104528A Active JP7602857B2 (ja) 2017-08-10 2018-05-31 加齢性肥満改善剤及び脂肪分解力改善剤
JP2018104527A Active JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022084727A Pending JP2022105650A (ja) 2017-08-10 2022-05-24 加齢性肥満改善剤及び脂肪分解力改善剤

Country Status (1)

Country Link
JP (4) JP7602857B2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021161117A (ja) * 2020-03-30 2021-10-11 ロート製薬株式会社 錠剤
JP2021187801A (ja) * 2020-06-03 2021-12-13 小林製薬株式会社 脂質排泄促進剤
JP2023056439A (ja) * 2021-10-07 2023-04-19 ロート製薬株式会社 固形組成物
JP7833346B2 (ja) * 2022-05-24 2026-03-19 小林製薬株式会社 錠剤組成物
JP2024062482A (ja) * 2022-10-25 2024-05-10 クラシエ株式会社 レプチン抵抗性改善剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852117A4 (en) * 1996-06-12 1999-02-03 Kyowa Hakko Kogyo Kk IMPROVEMENT OF LIPID METABOLISM
WO2008140064A1 (ja) * 2007-05-07 2008-11-20 Bbk Bio Corporation 生活習慣病の予防および改善のための栄養組成物
JP4355967B2 (ja) * 2008-01-25 2009-11-04 小林製薬株式会社 医薬組成物
JP5388602B2 (ja) 2008-01-25 2014-01-15 小林製薬株式会社 抗肥満用医薬組成物
JP2009242354A (ja) * 2008-03-31 2009-10-22 Kobayashi Pharmaceut Co Ltd 医薬組成物
US20090274781A1 (en) * 2008-05-02 2009-11-05 Asgen Pharmaceutical Co., Ltd. Anti-obesity agent
JP5204587B2 (ja) * 2008-08-20 2013-06-05 株式会社タニタ 体組成予測装置および体組成判定装置
CN103068400A (zh) * 2010-06-25 2013-04-24 阿斯顿大学 具有脂类动员性质的糖蛋白及其治疗用途
JP6086798B2 (ja) 2013-04-25 2017-03-01 小林製薬株式会社 錠剤の製造方法
JP6407545B2 (ja) * 2014-03-28 2018-10-17 小林製薬株式会社 医薬組成物
KR101760909B1 (ko) * 2014-11-21 2017-07-24 (주)휴온스 안정성이 개선된 한방 엑기스 함유 정제 조성물 및 이의 제조방법
KR101669140B1 (ko) * 2015-04-28 2016-10-26 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
CN105362766A (zh) 2015-12-05 2016-03-02 黑龙江江恒医药科技有限公司 一种防风通圣丸及其制备方法

Similar Documents

Publication Publication Date Title
JP6657296B2 (ja) 骨障害、軟骨障害又はその両方の管理又は改善用組成物及び方法
HRP20191094T1 (hr) Formulacije 4-amino-2-(2,6-dioksopiperidin-3-il)izoindolin-1,3-diona
JP2019510060A5 (cg-RX-API-DMAC10.html)
WO2013183062A3 (en) Palatable formulations of ibuprofen
WO2015120110A3 (en) Novel pharmaceutical formulations
JP2014532710A5 (cg-RX-API-DMAC10.html)
BRPI0414655B8 (pt) composição farmacêutica para o tratamento de doença vascular e cérebrovascular
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
HRP20241461T1 (hr) Aprocitentan za uporabu u liječenju hipertenzije i povezanih bolesti u kombinaciji s valsartanom
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
BRPI0922796A2 (pt) Comprimido farmacêutico para administração por via oral e método de fabricação do mesmo
MX2018006903A (es) Composicion farmaceutica.
JP2009537554A5 (cg-RX-API-DMAC10.html)
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
JP2016108327A5 (cg-RX-API-DMAC10.html)
Zihad et al. Assessment of the laxative activity of an ethanolic extract of Bambusa arundinacea (Retz.) Willd. shoot
CN102885752A (zh) 中草药牙膏配方
DK2155674T3 (da) Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander
JP2018529763A5 (cg-RX-API-DMAC10.html)
HRP20100208T8 (hr) Postupak liječenja akutnog rinosinusitisa
JP2011527984A5 (cg-RX-API-DMAC10.html)
JP2010523563A5 (cg-RX-API-DMAC10.html)
JP2022515068A5 (cg-RX-API-DMAC10.html)
WO2017215679A3 (zh) 苯丁酸氮芥的药物组合物及其抗抑郁的医药用途
Patil et al. Evaluation of anti-inflammatory and antiarthritic effect of sesbania grandiflora bark and fruit of Terminalia chebula in rats